Ability 0 7 0 7 B-language_fluency
to 8 10 8 10 I-language_fluency
complete 11 19 11 19 I-language_fluency
evaluation 20 30 20 30 I-language_fluency
surveys 31 38 31 38 I-language_fluency
in 39 41 39 41 I-language_fluency
English 42 49 42 49 I-language_fluency

Has 0 3 50 53 O
a 4 5 54 55 O
breast 6 12 56 62 B-cancer
cancer 13 19 63 69 I-cancer
recurrence 20 30 70 80 O
, 30 31 80 81 O
metastasis 32 42 82 92 O
, 42 43 92 93 O
or 44 46 94 96 O
another 47 54 97 104 O
interval 55 63 105 113 O
cancer 64 70 114 120 O
diagnosis 71 80 121 130 O
following 81 90 131 140 O
the 91 94 141 144 O
breast 95 101 145 151 O
cancer 102 108 152 158 O

Have 0 4 159 163 O
completed 5 14 164 173 O
all 15 18 174 177 O
surgery 19 26 178 185 B-treatment
, 26 27 185 186 O
radiation 28 37 187 196 B-treatment
, 37 38 196 197 O
and/or 39 45 198 204 O
chemotherapy 46 58 205 217 B-treatment
treatments 59 69 218 228 I-treatment
at 70 72 229 231 O
least 73 78 232 237 O
6 79 80 238 239 B-lower_bound
months 81 87 240 246 I-lower_bound
previously 88 98 247 257 O

Women 0 5 258 263 B-gender
diagnosed 6 15 264 273 O
with 16 20 274 278 O
early 21 26 279 284 O
stage 27 32 285 290 O
, 32 33 290 291 O
resectable 34 44 292 302 O
breast 45 51 303 309 B-cancer
cancer 52 58 310 316 I-cancer
( 59 60 317 318 O
Stage 60 65 318 323 O
0 66 67 324 325 B-lower_bound
, 67 68 325 326 O
I 69 70 327 328 O
, 70 71 328 329 O
II 72 74 330 332 O
, 74 75 332 333 O
or 76 78 334 336 O
III 79 82 337 340 B-upper_bound
) 82 83 340 341 O
prior 84 89 342 347 O
to 90 92 348 350 O
age 93 96 351 354 O
50 97 99 355 357 B-upper_bound
, 99 100 357 358 O
and 101 104 359 362 O
are 105 108 363 366 O
within 109 115 367 373 O
5 116 117 374 375 B-upper_bound
years 118 123 376 381 I-upper_bound
of 124 126 382 384 O
diagnosis 127 136 385 394 O

may 0 3 395 398 O
still 4 9 399 404 O
be 10 12 405 407 O
receiving 13 22 408 417 O
trastuzumab 23 34 418 429 B-treatment
or 35 37 430 432 O
endocrine 38 47 433 442 B-treatment
adjuvant 48 56 443 451 I-treatment
therapy 57 64 452 459 I-treatment

